Literature DB >> 1693347

What distinguishes tenascin from fibronectin?

R Chiquet-Ehrismann1.   

Abstract

Tenascin and fibronectin are two major extracellular matrix glycoproteins. They both consist of large disulfide-linked subunits composed of multiple structural domains. More than half of each molecule consists of so-called fibronectin type III repeats, but the other domains differ. Fibronectin is a dimer, whereas tenascin is a hexamer. Often fibronectin and tenascin are colocalized in tissues, but the occurrence of tenascin is much more restricted when compared with fibronectin. Tenascin is transiently expressed in many developing organs such as connective tissues, the mesenchyme of epithelial organs, and also the central and peripheral nervous systems, and it reappears in the stroma of many tumors. The distinctive and highly regulated expression of tenascin has provoked interest in trying to identify possible functions of tenascin in cell-cell and cell-substratum adhesion, cell migration, growth, and cell differentiation during morphogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693347     DOI: 10.1096/fasebj.4.9.1693347

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  34 in total

1.  Extracellular matrix protein tenascin-like gene found in human MHC class III region.

Authors:  K Matsumoto; N Ishihara; A Ando; H Inoko; T Ikemura
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Rostro-caudal polarity in the avian somite related to paraxial segmentation. A study on HNK-1, tenascin and neurofilament expression.

Authors:  R E Poelmann; M M Mentink; A C Gittenberger-de Groot
Journal:  Anat Embryol (Berl)       Date:  1994-08

3.  A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices.

Authors:  P Sriramarao; M A Bourdon
Journal:  Nucleic Acids Res       Date:  1993-01-11       Impact factor: 16.971

4.  Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues.

Authors:  R Chiquet-Ehrismann; Y Matsuoka; U Hofer; J Spring; C Bernasconi; M Chiquet
Journal:  Cell Regul       Date:  1991-11

5.  The change in tenascin expression in mouse uterus during early pregnancy.

Authors:  H Kida; M Taga; H Minaguchi; M Hanazono; T Ohashi; T Sakakura; M Kusakabe
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

6.  Localization of tenascin in human skin wounds--an immunohistochemical study.

Authors:  P Betz; A Nerlich; J Tübel; R Penning; W Eisenmenger
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

7.  Tenascin immunoreactivity in normal and pathological bone marrow.

Authors:  Y Soini; D Kamel; M Apaja-Sarkkinen; I Virtanen; V P Lehto
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

8.  Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo.

Authors:  D C Rockey; C N Housset; S L Friedman
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 9.  Tenascins, a growing family of extracellular matrix proteins.

Authors:  R Chiquet-Ehrismann
Journal:  Experientia       Date:  1995-09-29

10.  Enhanced tenascin expression in cervical and vulvar koilocytotic lesions.

Authors:  O Tiitta; T Wahlström; J Paavonen; A Linnala; S Sharma; V E Gould; I Virtanen
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.